Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Lindvall

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Journal of Biomolecular Screening|January 1, 2015
Large scale meta-analysis of fragment-based screening campaigns: privileged fragments and complementary technologiesPeter S Kutchukian, Anne Mai Wassermann, Mika K Lindvall, et al.
Clinical Cardiology|April 13, 1999
NC100100, a new echo contrast agent for the assessment of myocardial perfusion--safety and comparison with technetium-99m sestamibi single-photon emission computed tomography in a randomized multicenter studyT Binder, P Assayag, F Baer, et al.
Journal of the American College of Cardiology|November 11, 1998
Accuracy and feasibility of contrast echocardiography for detection of perfusion defects in routine practice: comparison with wall motion and technetium-99m sestamibi single-photon emission computed tomography. The Nycomed NC100100 InvestigatorsT H Marwick, R Brunken, N Meland, et al.
Molecular Cancer Research : MCR|February 21, 2014
Novel potent and selective inhibitors of p90 ribosomal S6 kinase reveal the heterogeneity of RSK function in MAPK-driven cancersIda Aronchik, Brent A Appleton, Stephen E Basham, et al.
ACS Medicinal Chemistry Letters|July 21, 2015
Optimization of a Dibenzodiazepine Hit to a Potent and Selective Allosteric PAK1 InhibitorAlexei S Karpov, Payman Amiri, Cornelia Bellamacina, et al.
Journal of Medicinal Chemistry|March 3, 2018
Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative BacteriaRobert J Moreau, Colin K Skepper, Brent A Appleton, et al.
Journal of Medicinal Chemistry|October 28, 2015
Identification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological MalignanciesMatthew T Burger, Gisele Nishiguchi, Wooseok Han, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Journal of Biomolecular Screening|January 1, 2015
Large scale meta-analysis of fragment-based screening campaigns: privileged fragments and complementary technologiesPeter S Kutchukian, Anne Mai Wassermann, Mika K Lindvall, et al.
Clinical Cardiology|April 13, 1999
NC100100, a new echo contrast agent for the assessment of myocardial perfusion--safety and comparison with technetium-99m sestamibi single-photon emission computed tomography in a randomized multicenter studyT Binder, P Assayag, F Baer, et al.
Journal of the American College of Cardiology|November 11, 1998
Accuracy and feasibility of contrast echocardiography for detection of perfusion defects in routine practice: comparison with wall motion and technetium-99m sestamibi single-photon emission computed tomography. The Nycomed NC100100 InvestigatorsT H Marwick, R Brunken, N Meland, et al.
Molecular Cancer Research : MCR|February 21, 2014
Novel potent and selective inhibitors of p90 ribosomal S6 kinase reveal the heterogeneity of RSK function in MAPK-driven cancersIda Aronchik, Brent A Appleton, Stephen E Basham, et al.
ACS Medicinal Chemistry Letters|July 21, 2015
Optimization of a Dibenzodiazepine Hit to a Potent and Selective Allosteric PAK1 InhibitorAlexei S Karpov, Payman Amiri, Cornelia Bellamacina, et al.
Journal of Medicinal Chemistry|March 3, 2018
Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative BacteriaRobert J Moreau, Colin K Skepper, Brent A Appleton, et al.
Journal of Medicinal Chemistry|October 28, 2015
Identification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological MalignanciesMatthew T Burger, Gisele Nishiguchi, Wooseok Han, et al.
Pageof 9